Mitochondria-targeted antioxidant supplementation for improving age-related vascular dysfunction in older adults: the role of circulating factors
线粒体靶向抗氧化剂补充剂可改善老年人与年龄相关的血管功能障碍:循环因子的作用
基本信息
- 批准号:10606926
- 负责人:
- 金额:$ 7.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-30 至 2025-03-29
- 项目状态:未结题
- 来源:
- 关键词:AdultAgeAge YearsAgingAntioxidantsAortaBackBiological AvailabilityBiomedical ResearchBloodBlood VesselsCardiovascular DiseasesCause of DeathCell physiologyChronicCirculationClinical TrialsCrossover DesignDataDevelopmentDouble-Blind MethodElderlyEndothelial CellsEndotheliumExposure toExtramural ActivitiesFundingFutureHumanInternationalInterventionLOX geneLaboratoriesLearningLow Density Lipoprotein ReceptorMediatingMediatorMentorsMicroRNAsMitochondriaMolecularMolecular and Cellular BiologyMorphologyNitric OxidePhasePhysiologyPlacebosPlasmaPositioning AttributePostdoctoral FellowProductionRandomizedReactive Oxygen SpeciesRecording of previous eventsResearchResearch PersonnelResearch Project GrantsResearch TrainingRisk ReductionRoleSamplingScientistSmall Interfering RNASourceSupplementationTrainingUnited States National Institutes of HealthVascular DiseasesVascular EndotheliumWomanage relatedbrachial arterycardiovascular disorder riskcardiovascular risk factorendothelial dysfunctionexperienceextracellular vesiclesimprovedin vivoinsightmenmiddle agenovelnovel strategiesoxidized low density lipoproteinpilot trialreceptor-mediated signalingsealskillsvascular endothelial dysfunction
项目摘要
PROJECT SUMMARY/ABSTRACT
The purpose of this F32 application is to support Dr. Kevin Murray, a promising first-year postdoctoral fellow
in the laboratory of Dr. Douglas Seals, to conduct original research and receive scientific training that will
prepare him to become an independent, extramurally funded investigator in the field of translational vascular
physiology aimed at identifying novel interventions for improving vascular function with aging and the
associated mechanisms of action. Dr. Murray will learn a variety of new technical, conceptual, and professional
skills, including focused training in translational cellular and molecular vascular physiology research, in addition
to training in conducting a clinical trial. His proposed research project will leverage his primary sponsor’s
ongoing NIH-funded R01-funded clinical trial that seeks to establish the efficacy of the mitochondria-targeted
antioxidant MitoQ for improving vascular endothelial function in older adults to determine (Aim 1) whether
changes in the circulating milieu following 3 months of chronic treatment with MitoQ improves endothelial cell
function by treating human aortic endothelial cells (HAECs) with plasma collected from subjects after MitoQ or
placebo treatment. He will also determine (Aim 2) if reductions in oxidized low-density lipoprotein (oxLDL)
following MitoQ treatment mediate improvements in endothelial cell function by ameliorating oxLDL-stimulated
mitochondrial fission. Lastly, he will also explore (Aim 3) the role of changes in extracellular vesicles (EVs) with
MitoQ treatment in mediating improvements in endothelial cell function and whether these potential changes
are associated with alterations to miRNA content of EVs. Age-related endothelial dysfunction is largely
mediated by reduced bioavailability of the vasoprotective molecule, nitric oxide (NO), as a result of excessive
production of reactive oxygen species (ROS). Dysfunctional mitochondria increase with age and are a major
source of excess ROS (mtROS) in the vasculature. MitoQ is a mitochondrial-targeted antioxidant and our
laboratory previously showed that 6-weeks of MitoQ supplementation in older adults improved NO-mediated
endothelium-dependent dilation. Preliminary data collected by Dr. Murray for this application suggest that
changes to the circulating milieu following MitoQ treatment increase NO bioavailability and decrease mtROS
bioactivity in HAECs ex vivo, extending the mechanisms of action by which MitoQ supplementation improves
endothelial function. Guided by these strong preliminary data, Dr. Murray will aim to establish changes to the
circulating milieu as a mechanism of action by which MitoQ treatment improves endothelial function by
leveraging plasma samples collected from subjects during his primary sponsor’s ongoing NIH-funded R01
clinical trial. The primary sponsor is an internationally recognized, NIH-funded scientist with a strong history of
successful mentoring in translational biomedical research. With his guidance, and that of his mentoring team,
Dr. Murray will be able to successfully complete the proposed research and training plan, preparing him to
succeed as an extramurally funded independent investigator in translational vascular physiology.
项目摘要/摘要
这个F32应用程序的目的是支持凯文·默里博士,一个有前途的第一年博士后研究员
在道格拉斯西尔斯博士的实验室里,进行原创性研究,并接受科学培训,
准备他成为一个独立的,在转化血管领域的研究者,
生理学,旨在确定新的干预措施,以改善血管功能与老化和
相关的作用机制。默里博士将学习各种新的技术,概念和专业
技能,包括转化细胞和分子血管生理学研究的重点培训,此外,
进行临床试验的培训。他提出的研究项目将利用他的主要赞助商的
正在进行的NIH资助的R 01资助的临床试验,旨在确定靶向的抗肿瘤药物的疗效。
抗氧化剂MitoQ用于改善老年人的血管内皮功能,以确定(目的1)是否
MitoQ慢性治疗3个月后循环环境的变化改善了内皮细胞
通过用从MitoQ或MitoQ后的受试者收集的血浆处理人主动脉内皮细胞(HAEC),
安慰剂治疗。他还将确定(目标2)氧化低密度脂蛋白(oxLDL)的减少是否
MitoQ治疗后,通过改善oxLDL刺激的内皮细胞功能,
线粒体分裂最后,他还将探索(目标3)细胞外囊泡(EV)变化的作用,
MitoQ治疗介导内皮细胞功能的改善,以及这些潜在的变化是否
与EV中miRNA含量的改变有关。血管内皮功能障碍主要是
通过血管保护分子一氧化氮(NO)的生物利用度降低介导,
产生活性氧(ROS)。线粒体功能障碍随着年龄的增长而增加,
血管系统中过量ROS(mtROS)的来源。MitoQ是一种针对肾脏的抗氧化剂,
实验室先前表明,老年人补充MitoQ 6周可改善NO介导的
内皮依赖性舒张。Murray博士为此应用收集的初步数据表明,
MitoQ治疗后循环环境的变化增加了NO的生物利用度并降低了mtROS
在HAEC中的离体生物活性,扩展了MitoQ补充改善的作用机制
内皮功能在这些强有力的初步数据的指导下,默里博士将致力于建立对
循环环境作为MitoQ治疗改善内皮功能的作用机制,
利用在其主要申办者正在进行的NIH资助的R 01期间从受试者中采集的血浆样本
临床试验主要申办者是一位国际公认的、NIH资助的科学家,
成功指导转化生物医学研究。在他和他的指导团队的指导下,
博士默里将能够成功地完成拟议的研究和培训计划,为他做好准备,
成功地作为一个在转化血管生理学的校外资助的独立研究者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin Owen Murray其他文献
Kevin Owen Murray的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 7.2万 - 项目类别:
Directed Grant